𝔖 Bobbio Scriptorium
✦   LIBER   ✦

403 POSTER Clinical responses in highly refractory solid tumor patients with oral MP-470, a multi-targeted tyrosine kinase inhibitor, in combination with standard of care chemotherapy regimens: preliminary report from a multi-institutional phase-1b clinical trial

✍ Scribed by A.W. Tolcher; M. Mita; M. Gordon; L. Rosen; A. Patnaik; G.D. Fine; G.S. Choy; G.I. Berk


Book ID
119599559
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
78 KB
Volume
6
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.